FFEC
ATRS

First Financial Equity Corporation’s Antares Pharma, Inc. ATRS Stock Holding History

First Financial Equity Corporation’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$81K Buy
+29,400
New +$70.7K 0.01% 435

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

First Financial Equity Corporation's ATRS Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Antares Pharma, Inc. (ATRS) in Q1 2017: 29,400 shares worth $81K. The stake represents 0.01% of the portfolio and ranks #435 among its holdings.

85 funds tracked by Wall St. Rank hold ATRS as of Q1 2017.

  • First Financial Equity Corporation held 29,400 shares of Antares Pharma, Inc. worth $81K as of Q1 2017.
  • Antares Pharma, Inc. was a new First Financial Equity Corporation position in Q1 2017.
  • Antares Pharma, Inc. made up 0.01% of First Financial Equity Corporation's portfolio in Q1 2017, its #435 holding.
  • 85 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.